之江生物
(688317)
| 流通市值：31.23亿 | | | 总市值：31.23亿 |
| 流通股本：1.92亿 | | | 总股本：1.92亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,744,475,186.36 | 2,765,562,458.72 | 2,760,515,051.97 | 2,769,495,158.09 |
| 应收票据及应收账款 | 76,228,303.43 | 84,148,790.28 | 99,094,173.13 | 102,096,171.23 |
| 其中：应收票据 | 879,546 | 539,827 | - | - |
| 应收账款 | 75,348,757.43 | 83,608,963.28 | 99,094,173.13 | 102,096,171.23 |
| 预付款项 | 12,788,745.39 | 12,494,571.66 | 13,677,928.84 | 12,583,112.99 |
| 其他应收款合计 | 6,901,504.14 | 6,849,450.05 | 9,637,347.4 | 7,378,558.62 |
| 存货 | 213,761,093.04 | 227,996,109.08 | 244,928,297.36 | 253,600,865.69 |
| 其他流动资产 | 18,123,637.24 | 22,100,327.65 | 20,319,168.07 | 20,885,634.42 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 3,072,278,469.6 | 3,119,151,707.44 | 3,148,171,966.77 | 3,166,039,501.04 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 97,497,105.22 | 97,688,306.39 | 100,458,093.38 | 101,052,593.95 |
| 投资性房地产 | - | 0 | 8,281,164.56 | 8,392,255.73 |
| 固定资产 | 704,264,631.87 | 717,897,483.63 | 724,452,937.71 | 734,335,470.87 |
| 在建工程 | 42,600 | 1,296,310 | 3,123,942.65 | 2,119,970.79 |
| 使用权资产 | 5,013,958.25 | 5,519,763.45 | 6,189,426.27 | 7,450,186.9 |
| 无形资产 | 5,394,713.01 | 5,616,515.49 | 5,838,317.97 | 6,060,120.45 |
| 商誉 | 5,404,994.34 | 5,404,994.34 | 5,404,994.34 | 5,404,994.34 |
| 长期待摊费用 | 3,968,822.15 | 2,549,677.9 | 2,703,866.98 | 2,858,056.06 |
| 递延所得税资产 | 40,183,918.06 | 38,931,486.56 | 37,600,879.6 | 37,163,823.07 |
| 其他非流动资产 | 2,431,051.32 | 2,431,051.32 | 2,255,351.32 | 3,314,081.85 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 864,201,794.22 | 877,335,589.08 | 896,308,974.78 | 908,151,554.01 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,936,480,263.82 | 3,996,487,296.52 | 4,044,480,941.55 | 4,074,191,055.05 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 78,107,635.31 | 87,234,440.81 | 98,348,707.74 | 120,578,010.73 |
| 应付账款 | 78,107,635.31 | 87,234,440.81 | 98,348,707.74 | 120,578,010.73 |
| 合同负债 | 13,419,119.45 | 17,097,571.81 | 20,017,800.57 | 24,024,336.2 |
| 应付职工薪酬 | 51,975,759.14 | 51,620,125.63 | 51,154,786.61 | 70,212,684.6 |
| 应交税费 | 3,202,379.82 | 2,895,392.01 | 8,162,109.3 | 4,002,856.23 |
| 其他应付款合计 | 5,846,561.96 | 6,569,430.92 | 14,170,868.31 | 14,041,767 |
| 一年内到期的非流动负债 | 1,464,821.36 | 1,597,812.59 | 1,413,115.16 | 2,810,078.11 |
| 其他流动负债 | 462,527.75 | 666,445.86 | 815,121.82 | 893,333.16 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 154,478,804.79 | 167,681,219.63 | 194,082,509.51 | 236,563,066.03 |
| 非流动负债: | | | | |
| 租赁负债 | 3,880,552.35 | 3,837,407.42 | 4,592,656.34 | 4,643,995.96 |
| 递延收益 | 4,716,698.41 | 5,640,912.23 | 6,616,880.93 | 7,592,849.61 |
| 递延所得税负债 | - | - | 364,852.9 | 454,027.99 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 8,597,250.76 | 9,478,319.65 | 11,574,390.17 | 12,690,873.56 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 163,076,055.55 | 177,159,539.28 | 205,656,899.68 | 249,253,939.59 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 192,157,999 | 194,704,350 | 194,704,350 | 194,704,350 |
| 资本公积 | 2,050,702,003.19 | 2,150,189,569.46 | 2,150,189,569.46 | 2,150,189,569.46 |
| 减:库存股 | 35,331,332.71 | 130,798,591.72 | 114,403,960.09 | 102,033,917.27 |
| 其他综合收益 | -7,700,635.79 | -7,358,296.53 | -5,158,595.36 | -4,508,650.25 |
| 盈余公积 | 97,352,175 | 97,352,175 | 97,352,175 | 97,352,175 |
| 未分配利润 | 1,476,223,999.58 | 1,515,238,551.03 | 1,516,140,502.86 | 1,489,233,588.52 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,773,404,208.27 | 3,819,327,757.24 | 3,838,824,041.87 | 3,824,937,115.46 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,773,404,208.27 | 3,819,327,757.24 | 3,838,824,041.87 | 3,824,937,115.46 |
| 负债和股东权益合计 | 3,936,480,263.82 | 3,996,487,296.52 | 4,044,480,941.55 | 4,074,191,055.05 |
| 公告日期 | 2024-10-30 | 2024-08-29 | 2024-04-29 | 2024-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |